Jing Wu

Title: Innovations and Contributions of Inventor Jing Wu

Introduction

Jing Wu is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds with therapeutic potential. With a total of 16 patents to his name, Wu's work exemplifies the intersection of science and technology in addressing critical health challenges.

Latest Patents

One of Jing Wu's latest patents is a multi-target tyrosine kinase inhibitor. This invention relates to a compound that exhibits protein kinase inhibitory activity, as demonstrated in formula (I). The compound is metabolized into an active small molecule, td32-4, which effectively inhibits tumor growth in vivo, achieving notable anti-tumor effects. Compared to td32-4, this new compound shows significantly improved solubility and oral bioavailability, along with strong anti-tumor activity in animal experiments. The patent also details a synthetic method for the compound and its applications in the pharmaceutical field.

Career Highlights

Throughout his career, Jing Wu has worked with several notable companies, including Aac Technologies Pte. Ltd. and Shenzhen Neptunus Pharmaceutical Research Institute Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Jing Wu has collaborated with various professionals in his field, including Ke Hua and Tian Tang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jing Wu's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in cancer treatment and other therapeutic areas.